A Study of LY2784544 in Participants With Myeloproliferative Neoplasms

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms	Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm	Active, not recruiting	Phase 2	2026-06-23		NCT01594723

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Eli Lilly and Company	370

23 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Albert Einstein College of Medicine	The Bronx	United States	25
Baptist Cancer Center	Memphis	United States	22
Cancer Center of Kansas	Wichita	United States	21
Cleveland Clinic Foundation	Cleveland	United States	370
Dana Farber Cancer Institute	Boston	United States	300
Dean Medical Center	Madison	United States	1
Greenebaum Comprehensive Cancer Center	Baltimore	United States	3
Highlands Oncology Group - Duplicate 2	Rogers	United States	2
Indiana Blood & Marrow Transplantation (IBMT)	Indianapolis	United States	1
Ingalls Memorial Hospital	Harvey	United States	100
Joe Arrington Cancer Center	Lubbock	United States	2
Lakeland Regional Cancer Center	Lakeland	United States	4
Medical College of Wisconsin	Milwaukee	United States	483
Mid Ohio Oncology Hematology	Columbus	United States	1
Nebraska Methodist Hospital	Omaha	United States	131
Norwalk Hospital	Norwalk	United States	43
Palm Beach Cancer Institue	West Palm Beach	United States	2
Providence St. Joseph's Medical Center	Burbank	United States	1
Sarah Cannon Cancer Center	Nashville	United States	11
Swedish Medical Center	Seattle	United States	29
Tennessee Oncology PLLC	Nashville	United States	14
Washington University Medical Center	St Louis	United States	6
Weill Cornell Medical College	New York	United States	35

Clinical trials